Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03696888
Other study ID # 2016/1088-31
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 7, 2018
Est. completion date August 15, 2020

Study information

Verified date November 2023
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the efficacy of a skills training web-based mobile phone application, Telecoach among individuals in the general population seeking help for their risky alcohol consumption on the Internet. The design is a two-armed randomized controlled design, and outcomes are measured in terms of changes in excessive alcohol use at follow up 6, 12 and 26 weeks after study initiation and baseline data gathering. The Telecoach web app delivers skills training in the form of exercises commonly used in psychosocial interventions for risky alcohol use. The controll condition is a web app providing information on the effects of alcohol on the consumers' health.


Description:

This study evaluates the efficacy of a skills training web-based mobile phone application, Telecoach among individuals in the general population seeking help for their risky alcohol consumption on the Internet. The design is a two-armed randomized controlled design, and outcomes are measured in terms of changes in excessive alcohol use at follow up 6, 12 and 26 weeks after study initiation and baseline data gathering. Individuals seeking help for problematic alcohol use on the internet will get access to a webpage with information about the study. Individuals leaving informed consent are asked to fill out questionnaires about alcohol use, depression, anxiety and information on gender and weight. Those with excessive alcohol use (>14 standard glasses/week for men and > 9 for women) are randomized into one of two groups: 1. Access to the Telecoach web-app and 2. Access to a control condition with an information-providing web-app. Outcomes on alcohol use are gathered by electronic self-registration at 6, 12 and 26 weeks after study initiation. Additional questions on the users' satisfaction with the app assigned to them and other support for problematic alcohol used during the research period at 26 weeks. The Telecoach web-app is a skills-training app developed for use on a mobile smart-phone. The skills-training components are common to psychosocial treatment protocols for problematic alcohol consumption. The control condition web-app is a simple text-based app providing information on the effects of alcohol on the consumers' health. Outcomes will be reported, analyzed and discussed in a scientific article.


Recruitment information / eligibility

Status Completed
Enrollment 678
Est. completion date August 15, 2020
Est. primary completion date January 15, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - = 18 years - Risky alcohol consumption defined as Alcohol Use Disorders Identification Test (AUDIT) scores of =6 points for women and = 8 points for men. Exclusion Criteria: - Severe depression, defined as a MADRS-S score of > 30 - Sucide risk, defined as a MADRS-S, item 9 (Lust for life) score > 4 - Drug abuse, defined as a score of = 8 on the DUDIT

Study Design


Intervention

Behavioral:
Telecoach
A skills-training web-app teaching skills for reducing problematic alcohol use.
TeleCoach control
A web-app providing information about the health-related consequences of alcohol consumption.

Locations

Country Name City State
Sweden Karolinska institutet, Department of Clinical Neuroscience, Center for Psychiatric Research Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in alcohol consumption according to the 7-day Timeline Followback (TLFB) Change in the total number of standard glasses (12g of ethanol) consumed for each day of the preceding 7 days at each timepoint compared. Time between screening measure and 26-week followup
Secondary Daily Drinking Questionnaire (DDQ) The number of standard glasses (12g of ethanol) consumed and over how many hours for each day of a typical week the last month. Baseline, 6, 12 and 26 week followups.
Secondary Alcohol Use Disorders Identification Test (AUDIT) 10 questions measuring alcohol consumption and alcohol-related problems. Baseline and 26-week followup.
Secondary Change in alcohol consumption according to the 7-day Timeline Followback (TLFB) Change in the total number of standard glasses (12g of ethanol) consumed for each day of the preceding 7 days at each timepoint compared. Baseline, 6- and 12-week followups.
Secondary Readiness Ruler A visual analogue scale measuring participants' motivation to change their alcohol consumption. Baseline and 26-week followup.
Secondary DSM-5 Alcohol use disorder criteria. Criteria for the diagnosis Alcohol use disorder in the the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Baseline
Secondary Penn Alcohol Craving Scale (PACS) 5 items to measure participants' craving for alcohol. Baseline, 6, 12 and 26 week followups.
Secondary Alcohol Abstinence Self Efficacy scale (AASE) 12 items for measuring self efficacy in the domain of abstaining from drinking alcohol. Baseline, 6, 12 and 26 week followups.
Secondary Drug Use Disorders Identification Test (DUDIT) 11 items for measuring participants' drug consumption and drug-related problems. Baseline
Secondary Montgomery Åsberg Depression Rating Scale - Self-rating version (MADRS-S) 9 questions measuring symptoms of depression Baseline, 6, 12 and 26 week followups.
Secondary Generalized Anxiety Disorder-7 (GAD-7) 7 questions measuring symptoms of anxiety Baseline, 6, 12 and 26 week followups.
Secondary Treatment questions (7 questions regarding access to other help and support for problematic alcohol use). 7 questions regarding access to other help and support for problematic alcohol use. Baseline and 26 week followup.
Secondary Usability questions regarding the participants' experience of using the web-app they were assigned. Questions regarding the participants' experience of using the web-app they were assigned. 26 week followup
See also
  Status Clinical Trial Phase
Recruiting NCT04788004 - Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse
Recruiting NCT05684094 - Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function N/A
Completed NCT03406039 - Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems N/A
Completed NCT03573167 - Mobile Phone-Based Motivational Interviewing in Kenya N/A
Completed NCT04817410 - ED Initiated Oral Naltrexone for AUD Phase 1
Active, not recruiting NCT04267692 - Harm Reduction Talking Circles for American Indians and Alaska Natives With Alcohol Use Disorders N/A
Completed NCT03872128 - The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders Phase 1
Recruiting NCT06030154 - Amplification of Positivity for Alcohol Use N/A
Active, not recruiting NCT05419128 - Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04203966 - Mental Health and Well-being of People Who Seek Help From Their Member of Parliament
Recruiting NCT05861843 - Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Enrolling by invitation NCT04128761 - Decreasing the Temporal Window in Individuals With Alcohol Use Disorder N/A
Not yet recruiting NCT06337721 - Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults N/A
Enrolling by invitation NCT02544581 - Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare N/A
Completed NCT02511886 - A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder Phase 2
Active, not recruiting NCT02185131 - Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Phase 2
Completed NCT01916941 - Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin N/A